Association between nebuliser therapies adherence and visit-to-visit variability of FEV1 in patients with cystic fibrosis
- 14 March 2023
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22 (4) , 702-705
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health and Care Research
This publication has 11 references indexed in Scilit:
- Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registryScientific Reports, 2020
- Rapid lung function decline in adults with early-stage cystic fibrosis lung diseaseJournal of Cystic Fibrosis, 2020
- Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled TrialAnnals of Pharmacotherapy, 2020
- ECFS best practice guidelines: the 2018 revisionJournal of Cystic Fibrosis, 2018
- Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcherJournal of Cystic Fibrosis, 2017
- Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosisEuropean Respiratory Journal, 2017
- Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung FunctionThe Journal of Pediatrics, 2016
- Medication adherence and visit-to-visit variability of systolic blood pressure in African Americans with chronic kidney disease in the AASK trialJournal of Human Hypertension, 2015
- Association Between Antihypertensive Medication Adherence and Visit‐to‐Visit Variability of Blood PressureThe Journal of Clinical Hypertension, 2012
- Lung function decline from adolescence to young adulthood in cystic fibrosisPediatric Pulmonology, 2011